• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒 E2 糖蛋白具有柔韧性和固有无序性的特征。

Flexibility and intrinsic disorder are conserved features of hepatitis C virus E2 glycoprotein.

机构信息

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, United Kingdom.

Institute of Structural and Molecular Biology, Birkbeck College, London, United Kingdom.

出版信息

PLoS Comput Biol. 2020 Feb 28;16(2):e1007710. doi: 10.1371/journal.pcbi.1007710. eCollection 2020 Feb.

DOI:10.1371/journal.pcbi.1007710
PMID:32109245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7065822/
Abstract

The glycoproteins of hepatitis C virus, E1E2, are unlike any other viral fusion machinery yet described, and are the current focus of immunogen design in HCV vaccine development; thus, making E1E2 both scientifically and medically important. We used pre-existing, but fragmentary, structures to model a complete ectodomain of the major glycoprotein E2 from three strains of HCV. We then performed molecular dynamic simulations to explore the conformational landscape of E2, revealing a number of important features. Despite high sequence divergence, and subtle differences in the models, E2 from different strains behave similarly, possessing a stable core flanked by highly flexible regions, some of which perform essential functions such as receptor binding. Comparison with sequence data suggest that this consistent behaviour is conferred by a network of conserved residues that act as hinge and anchor points throughout E2. The variable regions (HVR-1, HVR-2 and VR-3) exhibit particularly high flexibility, and bioinformatic analysis suggests that HVR-1 is a putative intrinsically disordered protein region. Dynamic cross-correlation analyses demonstrate intramolecular communication and suggest that specific regions, such as HVR-1, can exert influence throughout E2. To support our computational approach we performed small-angle X-ray scattering with purified E2 ectodomain; this data was consistent with our MD experiments, suggesting a compact globular core with peripheral flexible regions. This work captures the dynamic behaviour of E2 and has direct relevance to the interaction of HCV with cell-surface receptors and neutralising antibodies.

摘要

丙型肝炎病毒的糖蛋白 E1E2 与任何其他病毒融合机制都不同,是当前丙型肝炎病毒疫苗开发中免疫原设计的重点;因此,E1E2 既具有科学意义,也具有医学意义。我们使用现有的但不完整的结构来模拟丙型肝炎病毒三种毒株主要糖蛋白 E2 的完整外域。然后,我们进行了分子动力学模拟,以探索 E2 的构象景观,揭示了一些重要的特征。尽管存在高度的序列差异和模型中的细微差异,但来自不同毒株的 E2 表现相似,具有稳定的核心,周围是高度灵活的区域,其中一些区域执行诸如受体结合等基本功能。与序列数据的比较表明,这种一致的行为是由保守残基网络赋予的,这些残基在整个 E2 中充当铰链和锚固点。可变区(HVR-1、HVR-2 和 VR-3)表现出特别高的灵活性,生物信息学分析表明 HVR-1 是一个潜在的无序蛋白区域。动态互相关分析表明分子内存在通讯,并表明特定区域,如 HVR-1,可以在整个 E2 中发挥影响。为了支持我们的计算方法,我们对纯化的 E2 外域进行了小角度 X 射线散射;该数据与我们的 MD 实验一致,表明存在一个紧凑的球形核心和外围灵活的区域。这项工作捕获了 E2 的动态行为,与丙型肝炎病毒与细胞表面受体和中和抗体的相互作用直接相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/29464413b5ee/pcbi.1007710.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/d59d30e6a561/pcbi.1007710.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/932f8e3754e1/pcbi.1007710.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/7867f9c270ba/pcbi.1007710.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/507bb964195b/pcbi.1007710.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/dfacc43a6e3d/pcbi.1007710.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/6050b5aa3a6f/pcbi.1007710.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/978813c7a9e1/pcbi.1007710.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/894cb4ed8997/pcbi.1007710.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/29464413b5ee/pcbi.1007710.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/d59d30e6a561/pcbi.1007710.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/932f8e3754e1/pcbi.1007710.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/7867f9c270ba/pcbi.1007710.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/507bb964195b/pcbi.1007710.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/dfacc43a6e3d/pcbi.1007710.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/6050b5aa3a6f/pcbi.1007710.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/978813c7a9e1/pcbi.1007710.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/894cb4ed8997/pcbi.1007710.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30aa/7065822/29464413b5ee/pcbi.1007710.g009.jpg

相似文献

1
Flexibility and intrinsic disorder are conserved features of hepatitis C virus E2 glycoprotein.丙型肝炎病毒 E2 糖蛋白具有柔韧性和固有无序性的特征。
PLoS Comput Biol. 2020 Feb 28;16(2):e1007710. doi: 10.1371/journal.pcbi.1007710. eCollection 2020 Feb.
2
Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.丙型肝炎病毒糖蛋白 E2 的免疫球蛋白样结构域的构象灵活性。
mBio. 2017 May 16;8(3):e00382-17. doi: 10.1128/mBio.00382-17.
3
An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.一种优化的丙型肝炎病毒E2糖蛋白核心形成一种功能性同二聚体,可有效阻断病毒进入。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.01668-16. Print 2017 Mar 1.
4
Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.不同 HCV 糖蛋白 E2 变体的功能和免疫原性特征。
J Hepatol. 2019 Apr;70(4):593-602. doi: 10.1016/j.jhep.2018.11.003. Epub 2018 Nov 13.
5
Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.丙型肝炎病毒包膜糖蛋白E2中调节病毒对CD81和SRB1进入因子依赖性的保守残基的鉴定。
J Virol. 2014 Sep;88(18):10584-97. doi: 10.1128/JVI.01402-14. Epub 2014 Jul 2.
6
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.HCV 广泛中和抗体利用 CDRH3 二硫键基序识别 E2 糖蛋白位点,该位点可作为疫苗设计的靶标。
Cell Host Microbe. 2018 Nov 14;24(5):703-716.e3. doi: 10.1016/j.chom.2018.10.009.
7
Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.人源单克隆抗体针对 HCV E2 上新型构象表位簇,对 2a 基因型分离株的中和逃逸具有抗性。
PLoS Pathog. 2012;8(4):e1002653. doi: 10.1371/journal.ppat.1002653. Epub 2012 Apr 12.
8
An entropic safety catch controls hepatitis C virus entry and antibody resistance.一种熵安全锁控制丙型肝炎病毒进入和抗体耐药性。
Elife. 2022 Jul 7;11:e71854. doi: 10.7554/eLife.71854.
9
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.一种重组丙型肝炎病毒 1a 型 E1/E2 包膜糖蛋白疫苗可诱导产生抗体,通过 E2 的 N 端高变区 1 与清道夫受体 B1 的相互作用,使这些抗体对密切相关的 2a 株产生不同的中和作用。
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.00810-19. Print 2019 Nov 15.
10
Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.丙型肝炎病毒糖蛋白E2中一个被广泛中和抗体识别的保守抗原区域的结构灵活性
J Virol. 2015 Feb;89(4):2170-81. doi: 10.1128/JVI.02190-14. Epub 2014 Dec 3.

引用本文的文献

1
Exploring the globoid cell leukodystrophy protein network and therapeutic interventions.探索球样细胞脑白质营养不良蛋白网络和治疗干预措施。
Sci Rep. 2024 Aug 5;14(1):18067. doi: 10.1038/s41598-024-66437-8.
2
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development.丙型肝炎病毒 E1E2 结构、多样性及其对疫苗开发的影响。
Viruses. 2024 May 18;16(5):803. doi: 10.3390/v16050803.
3
Prospects for developing an Hepatitis C virus E1E2-based nanoparticle vaccine.开发基于丙型肝炎病毒 E1E2 的纳米颗粒疫苗的前景。

本文引用的文献

1
Why do eukaryotic proteins contain more intrinsically disordered regions?真核生物蛋白为何含有更多的无序区域?
PLoS Comput Biol. 2019 Jul 22;15(7):e1007186. doi: 10.1371/journal.pcbi.1007186. eCollection 2019 Jul.
2
Spatiotemporal Coupling of the Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet- Proximal Membranous Replication Compartment.通过创建一个靠近脂滴的膜复制隔室来实现丙型肝炎病毒复制周期的时空调控。
Cell Rep. 2019 Jun 18;27(12):3602-3617.e5. doi: 10.1016/j.celrep.2019.05.063.
3
Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis C.
Rev Med Virol. 2023 Sep;33(5):e2474. doi: 10.1002/rmv.2474. Epub 2023 Aug 11.
4
Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus.多价免疫可引发针对丙型肝炎病毒高变区 1 变异体的协同广谱中和免疫反应。
Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2220294120. doi: 10.1073/pnas.2220294120. Epub 2023 Jun 5.
5
Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection.丙型肝炎病毒高变区1抗体阻断E2-SR-B1相互作用以抑制病毒感染。
iScience. 2023 Mar 16;26(4):106421. doi: 10.1016/j.isci.2023.106421. eCollection 2023 Apr 21.
6
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate.一种经重排的丙型肝炎病毒糖蛋白纳米颗粒疫苗候选物诱导交叉中和抗体。
Nat Commun. 2022 Nov 25;13(1):7271. doi: 10.1038/s41467-022-34961-8.
7
Structure of the hepatitis C virus E1E2 glycoprotein complex.丙型肝炎病毒 E1E2 糖蛋白复合物的结构。
Science. 2022 Oct 21;378(6617):263-269. doi: 10.1126/science.abn9884. Epub 2022 Oct 20.
8
An entropic safety catch controls hepatitis C virus entry and antibody resistance.一种熵安全锁控制丙型肝炎病毒进入和抗体耐药性。
Elife. 2022 Jul 7;11:e71854. doi: 10.7554/eLife.71854.
9
E-Volve: understanding the impact of mutations in SARS-CoV-2 variants spike protein on antibodies and ACE2 affinity through patterns of chemical interactions at protein interfaces.E-Volve:通过蛋白质界面化学相互作用模式了解 SARS-CoV-2 变体刺突蛋白突变对抗体和 ACE2 亲和力的影响。
PeerJ. 2022 Mar 22;10:e13099. doi: 10.7717/peerj.13099. eCollection 2022.
10
Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance.肝病毒糖蛋白进化的宿主内分析揭示了与病毒持续存在和清除相关的特征。
Virus Evol. 2022 Feb 2;8(1):veac007. doi: 10.1093/ve/veac007. eCollection 2022.
抗丙型肝炎病毒 E2 肽抗体的库和中和活性在丙型肝炎自发清除患者中。
J Infect Dis. 2019 Aug 30;220(7):1209-1218. doi: 10.1093/infdis/jiz274.
4
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus.丙型肝炎病毒包膜糖蛋白 E1E2 异二聚体的功能表达和特性。
PLoS Pathog. 2019 May 22;15(5):e1007759. doi: 10.1371/journal.ppat.1007759. eCollection 2019 May.
5
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design.个体自然清除多种丙型肝炎病毒感染后产生的广谱中和抗体揭示了 E2 靶向和疫苗设计的分子决定因素。
PLoS Pathog. 2019 May 17;15(5):e1007772. doi: 10.1371/journal.ppat.1007772. eCollection 2019 May.
6
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2.广谱中和抗体靶向丙型肝炎病毒 E1E2 新弱点。
J Virol. 2019 Jun 28;93(14). doi: 10.1128/JVI.02070-18. Print 2019 Jul 15.
7
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.丙型肝炎病毒高变区 1 和 N 连接糖基化通过调节包膜构象调节病毒粒子中和作用。
Proc Natl Acad Sci U S A. 2019 May 14;116(20):10039-10047. doi: 10.1073/pnas.1822002116. Epub 2019 Apr 30.
8
Building a mechanistic mathematical model of hepatitis C virus entry.建立丙型肝炎病毒进入的机制数学模型。
PLoS Comput Biol. 2019 Mar 18;15(3):e1006905. doi: 10.1371/journal.pcbi.1006905. eCollection 2019 Mar.
9
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells.差异糖基化的丙型肝炎病毒 E2 包膜蛋白在哺乳动物和昆虫细胞中的抗原性和免疫原性。
J Virol. 2019 Mar 21;93(7). doi: 10.1128/JVI.01403-18. Print 2019 Apr 1.
10
Genetic and structural insights into broad neutralization of hepatitis C virus by human V1-69 antibodies.人类 V1-69 抗体对丙型肝炎病毒的广泛中和作用的遗传和结构见解。
Sci Adv. 2019 Jan 2;5(1):eaav1882. doi: 10.1126/sciadv.aav1882. eCollection 2019 Jan.